Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Pancreatic Neoplasms × Bortezomib × Clear all

Phase

Status

Completed 4 Terminated 3 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Multiple Myeloma 28 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Immunoglobulin Light-chain Amyloidosis 4 Recurrence 3 Neoplasms, Plasma Cell 3 Hematologic Neoplasms 3 Renal Insufficiency 2 Leukemia, Myeloid, Acute 2 Breast Neoplasms 2 beta-Thalassemia 1 Waldenstrom Macroglobulinemia 1 Thalassemia 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Peripheral Nervous System Diseases 1 Pancreatic Neoplasms 1 Neoplasms 1 Neoplasm, Residual 1 Metastatic Castration-resistant Prostate Cancer 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Burkitt Lymphoma 1 Anemia, Sickle Cell 1 Amyloidosis 1 Acute-Phase Reaction 1

Interventions

Gemcitabine 56 130-nm albumin-bound paclitaxel 28 Specimen Handling 18 Magnetic Resonance Spectroscopy 18 Taxes 17 Albumin-Bound Paclitaxel 17 Leucovorin 16 Fluorouracil 16 pembrolizumab 15 Oxaliplatin 15 Drug Therapy 14 Irinotecan 12 Cyclophosphamide 11 Biopsy 11 fludarabine 10 Blood Specimen Collection 10 olaparib 7 irinotecan sucrosofate 7 folfirinox 6 Cetuximab 6 Capecitabine 6 dehydroftorafur 5 Radiotherapy 5 Radiosurgery 5 Magnetic Resonance Imaging 5 Cisplatin 5 Bevacizumab 5 sintilimab 4 durvalumab 4 camrelizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06572813 2025-01-10

CISPD-7

Zhejiang University

Phase 1/2 Recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡